Galera Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Malvern, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Galera Therapeutics, Inc. has filed 373 SEC EDGAR filings since 10 Dec 2012

SEC filing history

Showing 226-250 of 373 matching filings.

Per page
25
Current page
10
SC 13G/A File 005-91201

AMENDED SCHEDULE 13G

Filing date
07 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jun 2021
Reporting date
28 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91201

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
30 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39114

DEFA14A

Filing date
28 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39114

DEF 14A

Filing date
28 Apr 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Mar 2021
Reporting date
26 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39114

8-K

Filing date
11 Mar 2021
Reporting date
11 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Feb 2021
Reporting date
18 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91201

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91201

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91201

GALERA THERAPEUTICS, INC.

Filing date
11 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91201

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91201

SC 13G/A

Filing date
01 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .